State of Wyoming’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,455
Closed -$54K 1926
2022
Q1
$54K Buy
1,455
+23
+2% +$817 0.03% 1008
2021
Q4
$65K Buy
1,432
+12
+0.8% +$463 0.03% 952
2021
Q3
$51K Buy
1,420
+1,088
+328% +$32K 0.03% 749
2021
Q2
$7K Buy
+332
New +$7.79K ﹤0.01% 1045

Other funds holding CYTK

State of Wyoming's CYTK Position: Q2 2022 in Review

State of Wyoming sold out of Cytokinetics (CYTK) in Q2 2022, closing a stake of 1,455 shares — an estimated $54K sold.

State of Wyoming first reported a position in CYTK in Q2 2021 and held it in 4 quarters. The position peaked at $65K in Q4 2021. 262 funds tracked by Wall St. Rank hold CYTK as of Q2 2022.

  • State of Wyoming reported no remaining Cytokinetics position as of Q2 2022 after selling out during the quarter.
  • State of Wyoming sold 1,455 Cytokinetics shares in Q2 2022, an estimated $54K.
  • State of Wyoming first reported a position in Cytokinetics in Q2 2021 and held it in 4 quarters.
  • State of Wyoming's Cytokinetics position peaked at $65K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2022.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.